1. Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4+ T Cells of Patients with Relapsing-Remitting Multiple Sclerosis. (12th May 2014) Authors: Meira, Maria; Sievers, Claudia; Hoffmann, Francine; Rasenack, Maria; Kuhle, Jens; Derfuss, Tobias; Kappos, Ludwig; Lindberg, Raija L. P. Other Names: Sánchez-Ramón Silvia Academic Editor. Journal: Journal of immunology research Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗